Por Professor Hendrik Tobias Arkenau
04.03.21
Oncólogo Radioterapia
TIL therapy promising new cancer treatment explained
TIL therapy is an exciting new experimental cancer treatment that could help extend the lives of many cancer patients who fail to respond to standard treatments. But what is TIL therapy, how does it work and which cancers can it treat? Professor Hendrik-Tobias Arkenau, a top medical oncologist and drug developer in London explains.
Por Professor Hendrik Tobias Arkenau
08.02.21
Inmunólogo
Before undergoing immunotherapy, it's important to consider some of the following factors mentioned in this article. Professor Hendrik-Tobias (Tobi) Arkenau is a highly established medical oncologist, we recently spoke with him about the types of immunotherapy, the side effects and the success rate. In this article, he answers some of your frequently asked questions related to this treatment.
Por Professor Hendrik Tobias Arkenau
26.01.21
Oncólogo Médico
What are clinical trials how could they benefit you?
Deciding whether to be part of a clinical trial? Clinical trials for new cancer drugs are widely considered to be beneficial to cancer patients by potentially improving their treatment outcomes. Professor Hendrik-Tobias Arkenau, leading medical oncologist and the founding medical director of The Sarah Cannon Research Institute, explains who has access to them and how you can get involved.
Artículos médicos más leídos
Artículos médicos destacados